04/01/2026
Jumping for joy over this news! This is going to be key to the quality of life for people with single ventricles.
âHistorically, the Fontan procedure marked a paradigm shift by enabling survival of patients who would otherwise face early mortality. However, decades later, the medical community confronts the unintended consequences of this complex physiology. This new initiative underscores a shift from life preservation towards life optimization â transforming reactive management into proactive, precision healthcare tailored to this vulnerable population. The vision is to create a sustainable ecosystem that encourages translational research from bench to bedside, accelerating scientific discoveries into clinical practice.â
In a landmark initiative poised to transform the clinical landscape for patients born with single ventricle heart disease, the American Heart Association (AHA) and Additional Ventures have announced a